Xeljanz: Arthritis Drug Treating Untreatable Eczema
Patients with moderate to severe eczema have been successfully treated, by Yale School of Medicine researchers, using a rheumatoid arthritis drug recently shown to reverse two other disfiguring skin conditions, vitiligo and alopecia areata. The …
Read more on ReliaWire

Anacor Pharmaceuticals (ANAC) Stock Spiked on Positive Phase 3 Study Results
NEW YORK (TheStreet) — Anacor Pharmaceuticals (ANAC – Get Report) shares closed trading up by 55.93% to $ 131.93 on heavy volume on Monday, after the company announced that the phase III studies of its topical eczema treatment achieved significant …
Read more on TheStreet.com